BPC-157 work centres on local angiogenic signalling, with Hsieh and colleagues (J Mol Med, 2017) reporting VEGFR2 upregulation and internalisation in human endothelial cells, and Chang and colleagues (J Appl Physiol, 2011) reporting increased focal adhesion kinase and paxillin phosphorylation in cultured rat tendon fibroblasts
Read our full guide on expired semaglutide to understand what happens when peptides degrade
A Vida-Flo Registered Nurse is here to help
The seller assumes no liability for misuse, injury, loss, or legal consequences resulting from improper or unauthorized use

You may also like Product Description BPC-157 Peptide | Buy BPC-157 UK | Research Use Only BPC-157 also known as Body Protection Compound 157, Stable Gastric Pentadecapeptide BPC 157, and PL-10 is a synthetic 15-amino acid peptide (GEPPPGKPADDAGLV, MW 1,419 Da) derived from a partial sequence of the endogenous body protection compound first isolated from human gastric juice, with no sequence homology to any other known peptide, that in pre-clinical research demonstrates a uniquely broad tissue-protective and repair-promoting profile spanning tendon, ligament, muscle, bone, and gastrointestinal tissue acting through a coordinated network of angiogenic, cytoprotective, and fibroblast-signalling mechanisms including VEGFR2/Akt/eNOS, GHR/JAK2, and HO-1 antioxidant pathways making it the most extensively studied gastric-derived peptide in pre-clinical tissue repair and cytoprotection research